Clal Biotechnology Industries Stock Filter Stocks by Fundamentals
CBI Stock | 45.00 0.80 1.81% |
Clal Biotechnology Industries fundamentals help investors to digest information that contributes to Clal Biotechnology's financial success or failures. It also enables traders to predict the movement of Clal Stock. The fundamental analysis module provides a way to measure Clal Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Clal Biotechnology stock.
Clal |
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
All Next | Launch Module |
Clal Fundamentals
Return On Equity | -0.45 | |||
Return On Asset | -0.12 | |||
Profit Margin | (1.14) % | |||
Operating Margin | (0.86) % | |||
Current Valuation | 89.12 M | |||
Shares Outstanding | 156.85 M | |||
Shares Owned By Insiders | 64.58 % | |||
Price To Earning | (218.28) X | |||
Price To Book | 0.68 X | |||
Price To Sales | 2.79 X | |||
Revenue | 76.96 M | |||
Gross Profit | 10.72 M | |||
EBITDA | (98.18 M) | |||
Net Income | (89.58 M) | |||
Cash And Equivalents | 94.71 M | |||
Cash Per Share | 0.59 X | |||
Total Debt | 52.28 M | |||
Debt To Equity | 6.30 % | |||
Current Ratio | 3.67 X | |||
Book Value Per Share | 0.84 X | |||
Cash Flow From Operations | (41.33 M) | |||
Earnings Per Share | (0.57) X | |||
Target Price | 30.0 | |||
Number Of Employees | 21 | |||
Beta | 0.9 | |||
Market Capitalization | 122.65 M | |||
Total Asset | 444.92 M | |||
Retained Earnings | (823 M) | |||
Working Capital | 193 M | |||
Current Asset | 254 M | |||
Current Liabilities | 61 M | |||
Z Score | -0.2 | |||
Annual Yield | 0.18 % | |||
Net Asset | 444.92 M |
About Clal Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clal Biotechnology Industries's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clal Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clal Biotechnology Industries based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Clal Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clal Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving together with Clal Stock
0.64 | GPGB | GP Global Power | PairCorr |
Moving against Clal Stock
0.44 | BOLT | BioLight Life Sciences | PairCorr |
The ability to find closely correlated positions to Clal Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clal Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clal Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clal Biotechnology Industries to buy it.
The correlation of Clal Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clal Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clal Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clal Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clal Biotechnology Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Clal Stock analysis
When running Clal Biotechnology's price analysis, check to measure Clal Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clal Biotechnology is operating at the current time. Most of Clal Biotechnology's value examination focuses on studying past and present price action to predict the probability of Clal Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clal Biotechnology's price. Additionally, you may evaluate how the addition of Clal Biotechnology to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |